SHR-3591

N/A

Report date: 2025/06/30 16:21:51
NME

Base Information

Drug NameSHR-3591
Drug Alias NameSHR-3591
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Hengrui Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Hengrui Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A